{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:58:49Z","timestamp":1776124729614,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.pain.2004.11.002","type":"journal-article","created":{"date-parts":[[2004,12,9]],"date-time":"2004-12-09T22:58:50Z","timestamp":1102633130000},"page":"316-322","source":"Crossref","is-referenced-by-count":52,"title":["Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model"],"prefix":"10.1097","volume":"113","author":[{"given":"Thomas","family":"Sycha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Anzenhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopold","family":"Schmetterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Chizh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Georg","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Gustorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210126","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1211\/0022357021387","article-title":"Rofecoxib: an update on physiochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.","volume":"55","author":"Ahuja","year":"2003","journal-title":"J Pharm Pharmacol"},{"key":"R2-11-20210126","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0304-3959(96)03199-5","article-title":"Secondary hyperalgesia to mechanical but not heat stimuli following a capsaicin injection in hairy skin.","volume":"68","author":"Ali","year":"1996","journal-title":"Pain"},{"key":"R3-11-20210126","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3959(01)00300-1","article-title":"Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study.","volume":"93","author":"Bajaj","year":"2001","journal-title":"Pain"},{"key":"R4-11-20210126","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0304-3959(98)00062-1","article-title":"Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in mean.","volume":"76","author":"Bickel","year":"1998","journal-title":"Pain"},{"key":"R5-11-20210126","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuroscience.2004.01.003","article-title":"Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain.","volume":"124","author":"Broom","year":"2004","journal-title":"Neuroscience"},{"key":"R6-11-20210126","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.290.18.2411","article-title":"Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomised controlled trial.","volume":"290","author":"Buvanendran","year":"2003","journal-title":"J Am Med Assoc"},{"key":"R7-11-20210126","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/archinte.160.12.1781","article-title":"A randomized trial of the efficiacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. RofecoxibIbuprofen Comparator Study group.","volume":"160","author":"Day","year":"2000","journal-title":"Arch Intern Med"},{"key":"R8-11-20210126","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s002280050736","article-title":"Pharmacokinetics, COX-2 specifity, and tolerability of supratherapeutic doses of rofecoxib in humans.","volume":"56","author":"Depre","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"R9-11-20210126","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/00000542-200212000-00035","article-title":"Mechanisms of postoperative pain: clinical indications for a contribution of central neuronal sensitization.","volume":"97","author":"Dirks","year":"2002","journal-title":"Anesthesiology"},{"key":"R10-11-20210126","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0009-9236(99)70113-X","article-title":"Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model.","volume":"65","author":"Ehrlich","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"R11-11-20210126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1213\/01.ANE.0000093224.77281.A5","article-title":"The sunburn pain model: the stability of primary and secondary hyperalgesia over 10 h in a crossover setting.","volume":"98","author":"Gustorff","year":"2004","journal-title":"Anesth Analg"},{"key":"R12-11-20210126","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1213\/01.ANE.0000095150.76735.5D","article-title":"The effects of remifentanil and gabapentin on hyperalgesia in a new extended inflammatory skin pain model in healthy volunteers.","volume":"98","author":"Gustorff","year":"2004","journal-title":"Anesth Analg"},{"key":"R13-11-20210126","first-page":"229","article-title":"Rofecoxib exerts no effect on platelet plug formation in healthy volunteers.","volume":"21","author":"Homoncik","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R14-11-20210126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0304-3959(94)00265-G","article-title":"Inflammatory models of cutaneous hyperalgesia are sensitive to effects of ibuprofen in man.","volume":"62","author":"Kilo","year":"1995","journal-title":"Pain"},{"key":"R15-11-20210126","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1152\/jn.01136.2002","article-title":"Central origin of secondary mechanical hyperalgesia.","volume":"90","author":"Klede","year":"2003","journal-title":"J Neurophysiol"},{"key":"R16-11-20210126","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1385\/JMN:21:3:191","article-title":"Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against gopamine deletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinsons disease.","volume":"21","author":"Klivenyi","year":"2003","journal-title":"J Mol Neurosci"},{"key":"R17-11-20210126","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1471-4159.2003.02160.x","article-title":"Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis.","volume":"88","author":"Klivenyi","year":"2004","journal-title":"J Neurochem"},{"key":"R18-11-20210126","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pain.2003.12.017","article-title":"The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans.","volume":"108","author":"Koppert","year":"2004","journal-title":"Pain"},{"key":"R19-11-20210126","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1152\/jn.1991.66.1.190","article-title":"Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms.","volume":"66","author":"LaMotte","year":"1991","journal-title":"J Neurophysiol"},{"key":"R20-11-20210126","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.1381521","article-title":"Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition.","volume":"257","author":"Malmberg","year":"1992","journal-title":"Science"},{"key":"R21-11-20210126","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-2999(94)90247-X","article-title":"Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test.","volume":"256","author":"Malmberg","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"R22-11-20210126","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1523\/JNEUROSCI.15-04-02768.1995","article-title":"Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats.","volume":"15","author":"Malmberg","year":"1995","journal-title":"J Neurosci"},{"key":"R23-11-20210126","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0304-3959(97)03361-7","article-title":"Characterisation of capsaicin-induced mechanical hyperalgesia as a marker for altered nociceptive processing in patients with rheumatoid arthritis.","volume":"71","author":"Morris","year":"1997","journal-title":"Pain"},{"key":"R24-11-20210126","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.14219\/jada.archive.2000.0119","article-title":"The optimal analgesic dose of rofecoxib: overview of six randomized controlled trials.","volume":"131","author":"Morrison","year":"2000","journal-title":"J Am Dent Assoc"},{"key":"R25-11-20210126","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.62.1.66","article-title":"Rofecoxib. No effect on Alzheimers disease in a 1-year, randomised, blinded, controlled study.","volume":"62","author":"Reines","year":"2004","journal-title":"Neurology"},{"key":"R26-11-20210126","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/35068566","article-title":"Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity.","volume":"410","author":"Samad","year":"2001","journal-title":"Nature"},{"key":"R27-11-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3959(03)00254-9","article-title":"Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation.","volume":"105","author":"Seybold","year":"2003","journal-title":"Pain"},{"key":"R28-11-20210126","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.0306-5251.2003.01869.x","article-title":"A simple pain model for the evaluation of analgesic effects of NSAIDs in healthy subjects.","volume":"56","author":"Sycha","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"R29-11-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01630479","article-title":"New insights into the mode of action of anti-inflammatory drugs.","volume":"44","author":"Vane","year":"1995","journal-title":"Inflamm Res"},{"key":"R31-11-20210126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00000542-200107000-00034","article-title":"Mechanism-based pain diagnosis: issues for analgesic drug development.","volume":"95","author":"Woolf","year":"2001","journal-title":"Anesthesiology"},{"key":"R30-11-20210126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0304-3959(98)00099-2","article-title":"Towards a mechanism-based classification of pain?","volume":"77","author":"Woolf","year":"1998","journal-title":"Pain"},{"key":"R33-11-20210126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0306-4522(96)00294-1","article-title":"Effect of spinal kainic acid receptor activation on spinal amino acid and prostaglandin E2 release in rat.","volume":"75","author":"Yang","year":"1996","journal-title":"Neuroscience"},{"key":"R34-11-20210126","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0304-3959(94)00132-X","article-title":"Heat pain thresholds: normative data and repeatability.","volume":"60","author":"Yarnitzky","year":"1995","journal-title":"Pain"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006396-200502000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T22:38:25Z","timestamp":1617921505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006396-200502000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2004.11.002","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}